Agrylin 0.5 mg Capsule

Description

Description:

Agrylin 0.5 mg Capsule contains Anagrelide Hydrochloride, a platelet-reducing agent primarily used to manage high platelet counts in patients with essential thrombocythemia. It works by inhibiting the maturation of megakaryocytes (platelet-forming cells) in the bone marrow, thereby reducing platelet production and lowering the risk of blood clot formation.

Contents: Each capsule contains 0.5mg of anagrelide hydrochloride.

Key Benefits

• Controls High Platelet Count: Effectively reduces elevated platelet levels

• Prevents Clotting Complications: Lowers the risk of thrombosis (blood clots)

• Targeted Bone Marrow Action: Regulates platelet production at the source

• Clinically Established Therapy: Widely used in essential thrombocythemia management

Uses: Treatment of essential thrombocythemia (ET) to lower elevated platelet counts.

osage & Administration

Dosage is individualized based on platelet count and patient response:

• Starting Dose: Usually 0.5 mg twice daily

• Dose may be gradually adjusted by the physician based on platelet levels

• Regular blood count monitoring is required during treatment

⚠️ Always take Agrylin exactly as prescribed by your healthcare professional. Do not adjust the dose without medical advice.

How it Works: Anagrelide inhibits the maturation of megakaryocytes, the cells that produce platelets, thereby reducing platelet production.

Directions for Use: Taken orally as directed by a healthcare provider, usually starting with a low dose that may be gradually increased.

Side Effects:

• Headache
• Palpitations
• Nausea
• Diarrhea
• Abdominal pain
• Dizziness
• Fluid retention

Precautions:

• Regular blood tests to monitor platelet counts are necessary.
• Use with caution in patients with heart conditions.